IREN, Posts

IREN Posts $263 Million Net Loss as Analysts Trim Targets on Delayed Revenue Ramp

Published on 11/18/2026 at 21:02 | Editorial boerse-global.de
IREN posted a $263M quarterly loss as its $4B annualized revenue goal slipped to January 2027. Cantor cut its price target to $47, keeping Overweight.
IREN Posts $263 Million Net Loss as Analysts Trim Targets on Delayed Revenue Ramp Illustration mit AI erstellt.

IREN's fiscal first-quarter report, released November 5, laid out a familiar tension for the AI infrastructure trade: robust contracted demand on one side, a bottom-line loss and a slipping delivery calendar on the other. The quarter, which closed September 30, showed a net loss of $263 million against total revenue of $228 million.

AI cloud services did the heavy lifting on the top line, generating $200 million of that total. Group-wide adjusted EBITDA came in at $66 million — positive on an operating basis, yet nowhere near enough to offset the net shortfall.

A $4 Billion Target, Pushed to the Right

Management used the earnings release to reaffirm that its goal of more than $4 billion in annualized recurring revenue is fully contracted and financed. What moved was the clock. The company shifted its timeline from the end of 2026 to January 2027, and acknowledged the milestone could slip as far as February.

Two factors drove the delay: a network reconfiguration requested by Microsoft and holdups among suppliers. IREN stressed that the pushback affects only the timing of the annualized run-rate, not the funding behind it.

Should investors sell immediately? Or is it worth buying IREN?

Cantor Slashes Its Price Target, Keeps Its Rating

Analyst reaction landed four days later, on November 9, and it cut hard in one direction while holding firm in another. Cantor Fitzgerald lowered its price target to $47 from $99 while keeping an Overweight rating. Brett Knoblauch, the Cantor analyst, pointed squarely at the deferred start of the contracted annualized revenue.

The distinction matters: annualized revenue is a figure extrapolated across a full year, not cash already booked for a completed fiscal period. A signed contract and the revenue it eventually produces are separate stages, and when the start date moves, the opportunity stays intact even as the yardstick for valuing it shifts.

J.P. Morgan made a parallel move the same day, trimming its target to $55 from $65 and likewise maintaining an Overweight stance. Read together, the two notes stop short of a retreat — both houses grew more cautious on price without abandoning their constructive view.

A Sector That Can't Decide

The broader market offered little cover. IREN traded down 3.6% on Wednesday evening amid sharp swings across the AI complex. Early in the session, Reuters had reported premarket gains for IREN as Nvidia's results and stronger revenue guidance lifted AI and data-center names. By later in the day, AP was describing violent reversals in Nvidia and other AI stocks, with CoreWeave also losing ground during the session.

IREN at a turning point? This analysis reveals what investors need to know now.

That whipsaw captures the prevailing mood: relief over AI demand one moment, doubt the next. Nvidia's outlook can ease worries about the appetite for compute, but it says nothing about when an individual operator like IREN converts that appetite into booked revenue. Industry growth and company-specific revenue ramp are related, though hardly interchangeable.

For IREN, the more telling test isn't whether the next sector headline sparks another rally. It's whether the company turns its contracted business into the revenue ramp it has promised. Wednesday's swings made that gap plainer — they didn't close it.

Ad

IREN Stock: New Analysis - 18 November

Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IREN analysis...

Disclaimer...
en | AU0000185993 | IREN | boerse | 70532852 |